Marinus pharmaceuticals inc.

Major-Pharmaceuticals

MRNS


170 North Radnor Chester Road
Radnor , PA 19087

Executive/
Director

Price

  • Last Close
  • $ 0.3
    $ -1.12 -79.08 %
    Dec 9, 2024
  • 52-Week High/Low
  • $11.21 - $1.1
  • YTD
  • -97.3%

  • Trading Volume
  • 3,526
  • Market Cap Full
  • $ 16.4M
  • Shares Outstanding
  • 54.6M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -15% -29.6% 75.3% -53.2% 45.6% -5% 27.1% -21.2% 73.4% -16.8%
Q2 29% -76.4% -22.6% 86.1% -2.2% 4% 15.9% -48.3% 57.4% -3%
Q3 -28.1% 43.3% 328.5% 30.7% -63.6% 8% -35% 37.4% -25.9% -
Q4 -8.4% -44.5% 31% -66.8% 45.2% -5.2% 1.8% -40.2% 44.2% -
J F M A M J J A S O N D
2024 -10.4% -2.5% -4.8% -3.8% - - - - - - - -
2023 59.6% 8.7% - 31.9% -21.9% 52.7% -2% -33.2% 13.2% -13.8% -3% 61.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-28%-87%708%-65%-23%454%-2%-66%173%-97%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.50 0.37 0.26 -0.15 -0.24 -1.28 -0.74 -0.52 -0.67
Q2 0.37 0.46 0.21 -0.24 -0.24 -0.64 -0.65 -1.06 -0.61
Q3 0.35 0.33 0.15 -0.27 -0.26 -0.51 -0.53 1.89 -0.61
Q4 0.45 0.31 0.20 -0.24 -0.99 -0.38 -0.77 -0.82 -
A 1.7 1.5 0.8 -0.9 -1.7 -2.8 -2.7 -0.5 -1.89

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2017 2018 2019 2020 2021 2022
Mar - - 52.5 86.7 36.6 37
Jun 40.5 - 52.6 86.7 36.6 37.1
Sep - 40.5 52.6 122.2 36.7 37.2
Dec - 40.5 53.9 30.6 36.8 37.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 3.6 2.5 0.5 - -
Total Asset Turnover 0.1 0.1 - - -
Leverage
Debt Ratio 0.4 0.3 - - -
Debt – Equity Ratio 0.9 0.8 - - -
Interest Coverage 1.2 -48.5 68 - -
Equity multiplier 0.1 0.1 - 0.1 -